Price $126.97 |
Market Cap
36.02B
|
Sector Health Care |
Div. Growth
9.80%
|
|
P/E
51.5
|
P/B
7.51
|
P/S
6.86
|
Dividend %
0.70%
|
|
P/CF
621.3
|
P/FCF
63.7
|
Op. Cash Flow
921K
|
FCF
1.8
|
|
Op. Margin
15.80%
|
Net Margin
13.50%
|
ROE
14.80%
|
ROI
10.00%
|
|
ROA
7.50%
|
EPS Growth
-31.60%
|
Current Ratio
2.3
|
Debt/Equity
46.90%
|
| Company | Price | P/E | Div. Yield | Market Cap ($Mil) | Rating |
|---|---|---|---|---|---|
| American Bio Medica Corporatio (ABMC) | $0.22 | - | - | 4.7M | Strong Buy |
| China Pharma Holdings, Inc. (CPHI) | $0.71 | - | - | 19.8M | Strong Buy |
| IntriCon Corporation (IIN) | $18.05 | - | - | 162.6M | Strong Buy |
| Teva Pharmaceutical Industries (TEVA) | $12.18 | - | - | 10.6B | Strong Buy |
| IRIDEX Corporation (IRIX) | $5.48 | - | - | 39.2M | Strong Buy |
Please note that all recommendations are based on our model's results and do not represent our personal opinion. The stock Rating process is purely mechanical.
All analysis relies on publicly available financial information. Learn More
